Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 9,280 shares at $49.58 ($461K) on 2021-09-15, disclosed to the SEC on 2021-09-17.
Open-market sale of $461k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.58 | 4,280 | $212K | 46.1% |
| 2 | $49.58 | 4,280 | $212K | 46.1% |
| 3 | $50.36 | 720 | $36K | 7.9% |
| Total | $49.64 avg | 9,280 | $461K | 100% |
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |